A Randomized, Double-blind, Multicenter, Phase2 Trial to Evaluate the Safety and Efficacy of YH1177 or YH1177-D Otic Soultion in Patients With Otitis Media and Otorrhea

Trial Profile

A Randomized, Double-blind, Multicenter, Phase2 Trial to Evaluate the Safety and Efficacy of YH1177 or YH1177-D Otic Soultion in Patients With Otitis Media and Otorrhea

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 02 Feb 2017

At a glance

  • Drugs Dexamethasone/piperacillin/tazobactam (Primary) ; Piperacillin/tazobactam (Primary)
  • Indications Otitis media; Otorrhoea
  • Focus Therapeutic Use
  • Sponsors Yuhan
  • Most Recent Events

    • 25 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2020.
    • 25 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2020.
    • 15 Jul 2016 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top